Trials / Sponsors / Orum Therapeutics USA, Inc.
Orum Therapeutics USA, Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors HER2-positive Breast Cancer, HER-2 Protein Overexpression, HER-2 Gene Amplification | Phase 1 | 2022-10-03 |